Status:
ACTIVE_NOT_RECRUITING
Impact of Metabolic Syndrome on Rehabilitation Outcomes in Rotator Cuff Injury
Lead Sponsor:
Elif Dilara Durmaz
Conditions:
Rotator Cuff Injury (RCI)
Metabolic Syndrome (MetS)
Eligibility:
All Genders
18-65 years
Brief Summary
This prospective comparative study aims to investigate the effect of Metabolic Syndrome (MetS) on the outcomes of a standardized rehabilitation program in patients with Rotator Cuff Injuries (RCI). Pa...
Detailed Description
This study aims to investigate the differences in shoulder function and rotator cuff tear outcomes between individuals with and without Metabolic Syndrome (MetS). Participants will be divided into two...
Eligibility Criteria
Inclusion
- Inclusion Criteria for the Non-MetS Group:
- Aged between 18-65 years
- Willing to participate in the study
- Unilateral Rotator Cuff Tear (RMY)
- Inclusion Criteria for the MetS Group:
- In addition to the above criteria, meeting at least three of the NCEP-ATP III consensus criteria for Metabolic Syndrome Stable metabolic syndrome (e.g., no significant medical changes in the last 3 months)
- \- Exclusion Criteria for All Participants:
- Inability to cooperate with the tests or presence of mental health issues
- Presence of cervical radiculopathy symptoms
- Presence of other orthopedic pathologies in the same shoulder (e.g., fracture, prosthesis, avascular necrosis, advanced shoulder osteoarthritis, frozen shoulder, severe scapular dyskinesia, neurological diseases, etc.)
- Presence of function-limiting neurological, vascular, or cardiac issues
- Local steroid injection to the shoulder within the last 3 months
- Receipt of physiotherapy or rehabilitation within the last 3 months
- Systemic rheumatic or inflammatory diseases
- Surgical history due to chronic rotator cuff tear
- Diagnosis of glenohumeral joint or acromioclavicular joint arthritis
- Severe scapular dysfunction or significant postural abnormalities
Exclusion
Key Trial Info
Start Date :
April 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 5 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06946472
Start Date
April 15 2025
End Date
March 5 2026
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Name: Karamanoğlu Mehmetbey University Faculty of Medicine, Yunus Emre Mah. Dr. Aziz Tarhan Cad. No:21 City: Karaman Postal Code: 70200 Country: Turkey
Karaman, Turkey (Türkiye), 70200